Results 51 to 60 of about 9,641 (223)

Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR‐Mutated Locally Advanced or Metastatic Lung Cancer

open access: yesInternational Journal of Cancer, EarlyView.
Non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations often exhibit significant tumor reduction following tyrosine kinase inhibitor (TKI) therapy. Residual tumors frequently remain, however, leading to drug resistance and disease progression.
Fedor Moiseenko   +31 more
wiley   +1 more source

PANORAMIC AITIA IN CHYLOTHORAX [PDF]

open access: yes
The etiology of chylothorax can be divided into a)Traumatic b)Spontaneous and c)Idiopathic. Traumatic chylothorax, usually following iatrogenic injury like oesophageal surgery accounts for0.3-5%.
Elilnambi Sundaramoorthy, Kathirvel
core   +2 more sources

A Case of Chyloma after Esophagectomy with Respiratory Dysfunction [PDF]

open access: yes, 2006
We report a case of intractable chylothorax with chyloma after esophagectomy that demonstrated respiratory dysfunction. A 55-year-old man underwent thoracoscopically esophagectomy for esophageal cancer.
花村, 徹   +6 more
core   +1 more source

Comparison of methods for defatted human milk and nutrient composition: An experimental study

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Human milk is considered the gold standard for infant nutrition; however, it is often discontinued in chylothorax and severe very long‐chain acyl‐CoA dehydrogenase (VLCAD) deficiency. As an alternative to complete human milk restriction, defatted human milk may be fed, though it may not fully support optimal infant growth and ...
Kristin Cheng   +4 more
wiley   +1 more source

Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre‐Operative PD1 CheckpOint Blockade and Receptor Activator of NF‐κB Ligand (RANKL) Inhibition in Non‐Small Cell Lung Cancer (NSCLC)—A Phase 1B/2 Trial

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Expanding on the growing evidence for neoadjuvant immunotherapy in resectable non‐small cell lung cancer, this study explored neoadjuvant nivolumab ± denosumab. Two of the 10 treated patients achieved a pathological complete response. CD8 T‐cell infiltration correlated with pathological response, warranting ongoing translational research to understand ...
Elizabeth Ahern   +11 more
wiley   +1 more source

一位胸部淋巴管瘤男孩經 肋膜腹膜腔引流管置入手術及放射線治療治療頑抗性乳糜胸 [PDF]

open access: yes, 2011
Persistent chylothorax in children, acquired or congenital, is a clinical challenge. The standard pediatric treatment involves conservative therapy , with restriction of dietary fats, total parenteral nutrition and drainage of the pleural effusion by ...
CHEN, WEI-CHOU;CHANG, YIH-LEONG;LEE, YUNG-CHIE   +1 more
core  

A transudative chylothorax associated with superior vena cava syndrome

open access: yesRespiratory Medicine Case Reports, 2019
The chylothorax is a lymphocyte predominant protein-discordant exudative pleural effusions with low lactate dehydrogenase and elevated triglyceride levels.
Adam Austin   +3 more
doaj   +1 more source

Direct Percutaneous Needle Puncture and Intrapulmonary Lymphatic Embolization for Treatment of Chylothorax in a Patient with Lymphoma

open access: yes대한영상의학회지, 2020
Lymphoma is a common cause of nontraumatic chylothorax. Clinical success rates of thoracic duct embolization are lower in patients with nontraumatic chylothorax compared to patients with traumatic chylothorax.
Lee Hwangbo   +3 more
doaj   +1 more source

Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non‐Small Cell Lung Cancer

open access: yesCancer Science, EarlyView.
The flow of this trial and the treatment schedule of adjuvant chemotherapy with nedaplatin plus docetaxel for completely resected non‐small cell lung cancer (NSCLC) (A). The primary endpoint of this study was tolerability, assessed by the completion rate of the planned four chemotherapy cycles. As a result, it was 74.3%, exceeding that reported for the
Koji Teramoto   +9 more
wiley   +1 more source

A Recurrent Itga9 Missense Mutation in Human Fetuses with Severe Chylothorax: Possible Correlation with Poor Response to Fetal Therapy [PDF]

open access: yes, 2011
OBJECTIVES: To assess the possible correlations between the reported candidate genes (VEGFR3, FOXC2, ITGA9 and ITGB1) and the clinical response in fetuses with severe congenital chylothorax (CC) treated by prenatal OK -432 pleurodesis.
MA, GWO-CHIN;LIU, CHIN-SAN;CHANG, SHUN-PING;YEH, KUN-TU;KE, YU-YUAN;CHEN, TZE-HO;WANG, BAO-TYAN;KUO, SHOU-JEN;SHIH, JIN-CHUNG;CHEN, MING   +1 more
core  

Home - About - Disclaimer - Privacy